Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for oxidative stress and mood outcomes in multiple sclerosis
IRCT20180515039662N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in multiple sclerosis (MS) comparing N-acetylcysteine with Placebo (2 arms). Primary endpoints: Serum glutathione, Malondialdehyde and 4 more. Started Jun 2018; status: completed.
02
Drugs
acetylcysteine
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on IRCT20180515039662N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180515039662N1.